A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

NCT06675929 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Compensated Liver Cirrhosis
Metabolic Dysfunction Associated Steatohepatitis (MASH)

Interventions

DRUG: BI 770371
DRUG: Placebo for BI 770371

Sponsor

Boehringer Ingelheim